Ignite Creation Date:
2025-12-24 @ 4:46 PM
Ignite Modification Date:
2026-01-25 @ 3:39 AM
Study NCT ID:
NCT01311050
Status:
UNKNOWN
Last Update Posted:
2011-12-13
First Post:
2011-03-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Trial of Capecitabine (Xeloda), Oxaliplatin and Irinotecan in Combination With Bevacizumab in 1st Line Treatment of Metastatic Colorectal Cancer
Sponsor:
King Faisal Specialist Hospital & Research Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-01
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2011-03-06
First Submit QC Date:
None
Study First Post Date:
2011-03-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-12-11
Last Update Post Date:
2011-12-13
Last Update Post Date Type:
ESTIMATED